The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Breast. 2021 Jun;57:62-70. doi: 10.1016/j.breast.2021.03.001. Epub 2021 Mar 17.
The potential recurrence rate of malignant phyllodes tumors (MPTs) of the breast is high, and the prognostic factors are still unclear. We therefore aim to study the factors affecting the outcome of MPTs.
A retrospective review of MPT patients treated from 2006 to 2020 at our institution was conducted. Univariate and multivariate Cox proportional hazard models were used to examine the influence of different variables on RFS. Moreover, significant prognostic factors were combined to construct the nomogram to predict the probability of relapse occurring in MPT patients. The 5-year and 10-year RFS rates were estimated using the Kaplan-Meier method.
During the study period, 188 MPT patients were identified. The presence of malignant heterologous elements was observed in 23 (12.2%) patients with MPT, and the patients with malignant heterologous elements who received chemotherapy had longer RFS, which could reduce the risk of recurrence (p = 0.022). Recurrence occurred in 56/188 (29.8%) patients, of whom 47 experienced local recurrence and 11 experienced distant metastases. The 5-year and 10-year cumulative RFS rates were 77.5% and 70.1%, respectively. Age (p = 0.041), fibroadenoma surgery history (p = 0.004), surgical margins (p = 0.001) and malignant heterologous elements (p < 0.001) were independent risk factors for postoperative RFS. Subsequently, a nomogram was built, with a C-index of 0.64 (95% CI: 0.629-0.661), to predict the risk of recurrence.
The results of this study showed that younger age, fibroadenoma surgery history, malignant heterologous elements and surgical margins <1 cm predict a higher incidence of recurrence in MPT patients. Patients with malignant heterologous elements treated with chemotherapy could have a reduced risk of recurrence.
乳腺叶状肿瘤(MPT)的潜在复发率较高,其预后因素仍不清楚。因此,我们旨在研究影响 MPT 患者预后的因素。
对 2006 年至 2020 年在我院治疗的 MPT 患者进行回顾性分析。采用单因素和多因素 Cox 比例风险模型分析不同变量对 RFS 的影响。此外,将显著的预后因素组合起来,构建列线图以预测 MPT 患者发生复发的概率。采用 Kaplan-Meier 法估计 5 年和 10 年 RFS 率。
在研究期间,共确定了 188 例 MPT 患者。在 23 例(12.2%)MPT 患者中存在恶性异源成分,接受化疗的恶性异源成分患者 RFS 更长,复发风险降低(p=0.022)。188 例患者中有 56 例(29.8%)复发,其中 47 例局部复发,11 例远处转移。5 年和 10 年累积 RFS 率分别为 77.5%和 70.1%。年龄(p=0.041)、纤维腺瘤手术史(p=0.004)、手术切缘(p=0.001)和恶性异源成分(p<0.001)是术后 RFS 的独立危险因素。随后,建立了一个列线图,C 指数为 0.64(95%CI:0.629-0.661),用于预测复发风险。
本研究结果表明,年龄较小、纤维腺瘤手术史、恶性异源成分和手术切缘<1cm 预测 MPT 患者复发率较高。接受化疗的恶性异源成分患者复发风险可能降低。